Currently, the FDA approves only one medication specifically for hypoactive sexual desire disorder (HSDD) in premenopausal women: Flibanserin (Addyi). This medication works differently than medications for male erectile dysfunction; it targets brain neurotransmitters believed to influence sexual desire.
Understanding Addyi
Addyi requires a prescription and comes with potential side effects, including dizziness, nausea, and fatigue. Doctors carefully assess patient suitability due to potential interactions with alcohol and certain other medications. It’s crucial to discuss these risks and benefits with your physician.
Beyond Addyi: Other Options
While Addyi is the only FDA-approved medication directly targeting HSDD, other treatments address aspects of female sexual dysfunction. These include topical creams containing testosterone, which can improve arousal. Therapy, including sex therapy and cognitive behavioral therapy, can significantly improve various aspects of sexual health by addressing psychological contributors to dysfunction. Lifestyle changes, such as improving sleep and managing stress, also play a crucial role.
Always consult a healthcare professional before starting any treatment for female sexual dysfunction. They can properly diagnose the issue, discuss treatment options suitable for your individual needs, and monitor for any side effects.
